BIOMARKER:

EGFR exon 18-25 duplication

Entrez ID:

Related biomarkers:

‹

›

EGFR exon 18-25 duplication EGFR exon 18-25 duplication	Non Small Cell Lung Cancer NSCLC	erlotinib Sensitive: C4 – Case Studies Thorac Cancer - 3 weeks
EGFR exon 18-25 duplication EGFR exon 18-25 duplication	Non Small Cell Lung Cancer NSCLC	osimertinib Sensitive: C4 – Case Studies Anticancer Drugs - 3 weeks
EGFR exon 18-25 duplication EGFR exon 18-25 duplication	Lung Adenocarcinoma LUAD	afatinib Sensitive: C3 – Early Trials

Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.

Associations